Myriad Genetics, Inc. (MYGN) Tops Q4 EPS by 9c; Guides Above the Street

August 13, 2013 4:07 PM

Myriad Genetics, Inc. (NASDAQ: MYGN) reported Q4 EPS of $0.53, $0.09 better than the analyst estimate of $0.44. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found